Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 19:19:12099-12110.
doi: 10.2147/IJN.S487519. eCollection 2024.

Curcumin-Loaded Long-Circulation Liposomes Ameliorate Insulin Resistance in Type 2 Diabetic Mice

Affiliations

Curcumin-Loaded Long-Circulation Liposomes Ameliorate Insulin Resistance in Type 2 Diabetic Mice

Kang-Xin Li et al. Int J Nanomedicine. .

Abstract

Introduction: Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterised by insulin resistance, hyperglycaemia, and inflammation, with oxidative stress contributing to its progression. Curcumin (CUR), known for its anti-inflammatory, antioxidant, and insulin sensitising effects, has shown potential for the treatment of T2DM but is limited by low solubility and bioavailability. This study investigated long-circulating curcumin-loaded liposomes (CUR-LPs) to improve curcumin stability, solubility, and circulation and assessed their effect on insulin resistance in a murine model of T2DM.

Methods: CUR-LPs were prepared using the ethanol injection method and characterized for morphology, particle size, zeta potential, encapsulation efficiency, drug-loading capacity, and in vitro release. Cell viability was tested on murine L929 cells. In a T2DM murine model, after four weeks of CUR-LP treatment, inflammatory markers TNF-α and IL-6 were measured by real-time polymerase chain reaction, and liver tissues were analyzed for glutathione (GSH) and superoxide dismutase (SOD) via colorimetry.

Results: CUR-LPs were spherical, with an average diameter of (249 ± 2.3) nm and a zeta potential of (-33.5 ± 0.8) mV. They exhibited an encapsulation efficiency of (99.2 ± 0.5) %and a drug-loading capacity of (1.63 ± 0.02) %. CUR embedding in liposomes significantly maintained CUR release. In L929 cells, over 80% viability was maintained at 12 uM CUR concentration after 24 h. In HFD/STZ-induced T2DM mice, CUR-LPs improved blood glucose and insulin levels more efficiently than free CUR, and CUR-LPs also reduced hepatic inflammation (TNF-α, IL-6), enhanced hepatic GSH and SOD, and attenuated liver injury.

Conclusion: CUR-LPs improved glucose metabolism and insulin resistance in HFD/STZ-induced T2DM mice, which may be associated with a decrease in liver inflammation and oxidative stress.

Keywords: T2DM; curcumin; glucose metabolism; insulin resistance; liposomes; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declared no conflict of interest.

Figures

Figure 1
Figure 1
The transmission electron microscope images of CUR-LPs (×40000 Magnification, scale bar: 100 nm).
Figure 2
Figure 2
In vitro release of CUR from different preparations detected by dialysis method (n=3). The release medium was physiological saline containing 1.0% Tween 80 with pH adjusted to 7.0.
Figure 3
Figure 3
CCK-8 assays of CUR-LPs against L929 cells within 24 h (n=3).
Figure 4
Figure 4
Effect of CUR-LPs on body weight and fasting blood glucose level of T2DM mice. Normal diet: a normal diet group (0.9% sodium chloride, 5mg/kg, i.v., n=6), T2DM+Vehicle: a diabetic model control group (0.9% sodium chloride, 5mg/kg, i.v., T2DM, n=6), T2DM+Free CUR-L: a low-dose free curcumin treatment group (5mg/kg, i.g., n=6), T2DM+Free CUR-H: a high-dose free curcumin treatment group (50mg/kg, i.g., n=6), T2DM+Empty LPs: an empty liposome group (5mg/kg, i.v., n=6), T2DM+ CUR-LPs: a long-circulation liposomes loaded with CUR group (5mg/kg, i.v., n=6). (A) Description of the whole experimental process. (B) The body weight of T2DM mice treated with different ways. (C)The blood glucose level of T2DM mice treated with different ways. *p < 0.05 and **p < 0.01 vs T2DM+Vehicle.
Figure 5
Figure 5
Effect of CUR-LPs on insulin and HOMA-IR level of T2DM mice. (A)Evaluation of blood glucose levels in mice treated with different treatments. (B)The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated using the formula: HOMA-IR = [fasting plasma glucose (mmol/L) × fasting plasma insulin (mU/L)]/22.5. *p < 0.05, **p < 0.01 vs T2DM+Vehicle.
Figure 6
Figure 6
CUR-LPs attenuated liver inflammation and injury in T2DM mice. Mice with diabetes, induced by HFD/STZ, were treated with Free CUR, CUR-LPs, or Empty LPs. The expression of inflammatory cytokines TNF-α (A) and IL-6 (B) in the liver of HFD/STZ-induced T2DM mice were measured by RT-PCR. Liver tissues were fixed and sectioned for further analysis. (C and D) Hematoxylin and eosin staining was conducted for histochemical examination of liver tissue (original magnification 20×). *p < 0.05 and **p < 0.01, ***p < 0.001 vs T2DM+Vehicle.
Figure 7
Figure 7
CUR-LPs alleviated oxidative stress in T2DM mice. The levels of GSH (A) and SOD (B) in liver of mice treated with different methods were detected. *p < 0.05, ***p < 0.001 vs T2DM+Vehicle.

References

    1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34 Suppl 1(Suppl 1):S62–S69. doi:10.2337/dc11-S062 - DOI - PMC - PubMed
    1. Khalid M, Alkaabi J, Khan M, Adem A. Insulin signal transduction perturbations in insulin resistance. Int J Mol Sci. 2021;22(16):8590. doi:10.3390/ijms22168590 - DOI - PMC - PubMed
    1. Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5):1835. doi:10.3390/ijms21051835 - DOI - PMC - PubMed
    1. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–1801. doi:10.1172/JCI29069 - DOI - PMC - PubMed
    1. Ding S, Xu S, Ma Y, Liu G, Jang H, Fang J. Modulatory mechanisms of the NLRP3 inflammasomes in diabetes. Biomolecules. 2019;9(12):850. doi:10.3390/biom9120850 - DOI - PMC - PubMed

MeSH terms